Inhaled flecanide developer InCarda Therapeutics has named former Arena Pharmaceuticals executive Robert Lisicki as CEO, succeeding Grace Colón who the company says "intends to pursue other leadership opportunities within the life science space" but will continue to consult for InCarda. In addition to having served as Chief Commercial Officer at Arena, Lisicki … [Read more...] about InCarda Therapeutics names Robert Lisicki as CEO
People
Badrul Chowdhury to join PMI as Chief Life Sciences Officer, Smoke-Free Products
Shortly after Savara announced the resignation of Badrul Chowdhury as its Chief Medical Officer, Philip Morris International (PMI) has announced the appointment of Chowdhury as PMI's new Chief Life Sciences Officer, Smoke-Free Products, effective in January 2023. Chowdhury, a former Director of the FDA's Division of Pulmonary, Allergy, and Rheumatology Products, will … [Read more...] about Badrul Chowdhury to join PMI as Chief Life Sciences Officer, Smoke-Free Products
Badrul Chowdhury resigns as Savara’s Chief Medical Officer
Savara has announced the resignation of Badrul Chowdhury as Chief Medical Officer, effective September 9, 2022. Chowdhury, a former Director of the FDA's Division of Pulmonary, Allergy, and Rheumatology Products, joined Savara as CMO in November 2019. The company did not cite any reason why Chowdhury was leaving the company or any indication of what he planned to do … [Read more...] about Badrul Chowdhury resigns as Savara’s Chief Medical Officer
Verona announces appointments in preparation for potential commercialization of ensifentrine
Verona Pharma, which recently announced that a Phase 3 trial of its nebulized ensifentrine for the treatment of COPD met its primary endpoint, has announced the appointments of Matthew Casbon as VP of Sales, Marketing, and Training and Matthew Rysavy as VP of Market Access and Trade in preparation for potential commercialization. Casbon was most recently Chief … [Read more...] about Verona announces appointments in preparation for potential commercialization of ensifentrine
Nob Hill names Noel Greenberger as CEO, gets $1.7 million grant for development of a nebulized dry powder antifungal
Dry powder nebulizer developer Nob Hill Therapeutics announced the appointment of Noel Greenberger as its new CEO, replacing interim CEO Yun Li as of September 1, and said that it has received a Department of Health and Human Services (HHS) Small Business Innovation Research (SBIR) Phase 2 grant of up to $1.73 million for development of a dry powder antifungal … [Read more...] about Nob Hill names Noel Greenberger as CEO, gets $1.7 million grant for development of a nebulized dry powder antifungal
Respira Technologies names Brian Quigley as CEO
California-based nebulizer developer Respira Technologies has announced that Chief Operating Officer Brian Quigley will replace company founder Mario Danek as CEO, and Danek will take over the role of Chief Technology Officer. Quigley joined the company in 2020 after having spent most of his career in various positions at tobacco company Altria, including a stint … [Read more...] about Respira Technologies names Brian Quigley as CEO
Proveris Scientific announces the hire of Alyssa Rubino as Technical Data Scientist
OINDP characterization specialist Proveris Scientific announced that former Proveris Associate Product Manager Alyssa Rubino has rejoined the company as a Technical Data Scientist at Proveris Laboratories. Rubino, who was most recently Medical and Dental Product Manager at Tekscan, had originally joined Proveris as a Product Applications Engineer in 2014. … [Read more...] about Proveris Scientific announces the hire of Alyssa Rubino as Technical Data Scientist
Meissa Vaccines names Frank Glavin as CEO
Intranasal vaccine developer Meissa Vaccines has announced that Martin Moore is stepping down as the company's CEO and Frank Glavin has joined the company as the new Chief Executive Officer. Moore will stay with Meissa as Chief Scientific Officer. Glavin was most recently CEO of Orphan Technologies and was previously Head of Neovii Biotech North America. Meissa … [Read more...] about Meissa Vaccines names Frank Glavin as CEO
Adherium names Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs
Hailie inhaler monitoring system maker Adherium has announced the appointment of Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs. Creaven-Capasso has been a long-time regulatory affairs consultant; earlier in her career, she also held QA positions at several companies, including Xoma and Medtronic. Adherium received 510(k) clearance for its next … [Read more...] about Adherium names Tara Creaven-Capasso as VP of Quality, Regulatory and Clinical Affairs
Proveris names Ramesh Chand as Associate Director of Proveris Laboratories
Proveris Scientific has named Ramesh Chand as Associate Director of Proveris Laboratories, the company's contract testing business, which launched in May 2020. Chand was most recently Principal Scientist in Respiratory Drug Product Development at Moderna and previously held positions in OINDP research at GSK, Lovelace Biomedical, and Amneal … [Read more...] about Proveris names Ramesh Chand as Associate Director of Proveris Laboratories